235 related articles for article (PubMed ID: 8961961)
1. A low-barrier hydrogen bond in subtilisin: 1H and 15N NMR studies with peptidyl trifluoromethyl ketones.
Halkides CJ; Wu YQ; Murray CJ
Biochemistry; 1996 Dec; 35(49):15941-8. PubMed ID: 8961961
[TBL] [Abstract][Full Text] [Related]
2. Correlations of the basicity of His 57 with transition state analogue binding, substrate reactivity, and the strength of the low-barrier hydrogen bond in chymotrypsin.
Lin J; Cassidy CS; Frey PA
Biochemistry; 1998 Aug; 37(34):11940-8. PubMed ID: 9718318
[TBL] [Abstract][Full Text] [Related]
3. NMR studies of the role of hydrogen bonding in the mechanism of triosephosphate isomerase.
Harris TK; Abeygunawardana C; Mildvan AS
Biochemistry; 1997 Dec; 36(48):14661-75. PubMed ID: 9398185
[TBL] [Abstract][Full Text] [Related]
4. The deuterium isotope effect on the NMR signal of the low-barrier hydrogen bond in a transition-state analog complex of chymotrypsin.
Cassidy CS; Lin J; Frey PA
Biochem Biophys Res Commun; 2000 Jul; 273(2):789-92. PubMed ID: 10873682
[TBL] [Abstract][Full Text] [Related]
5. A new concept for the mechanism of action of chymotrypsin: the role of the low-barrier hydrogen bond.
Cassidy CS; Lin J; Frey PA
Biochemistry; 1997 Apr; 36(15):4576-84. PubMed ID: 9109667
[TBL] [Abstract][Full Text] [Related]
6. Protonation-state dependence of hydrogen bond strengths and exchange rates in a serine protease catalytic triad: bovine chymotrypsinogen A.
Markley JL; Westler WM
Biochemistry; 1996 Aug; 35(34):11092-7. PubMed ID: 8780512
[TBL] [Abstract][Full Text] [Related]
7. 15N and 1H NMR spectroscopy of the catalytic histidine in chloromethyl ketone-inhibited complexes of serine proteases.
Tsilikounas E; Rao T; Gutheil WG; Bachovchin WW
Biochemistry; 1996 Feb; 35(7):2437-44. PubMed ID: 8652587
[TBL] [Abstract][Full Text] [Related]
8. Identification of histidine tautomers in proteins by 2D 1H/13C(delta2) one-bond correlated NMR.
Sudmeier JL; Bradshaw EM; Haddad KE; Day RM; Thalhauser CJ; Bullock PA; Bachovchin WW
J Am Chem Soc; 2003 Jul; 125(28):8430-1. PubMed ID: 12848537
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen bonding at the active site of delta 5-3-ketosteroid isomerase.
Zhao Q; Abeygunawardana C; Gittis AG; Mildvan AS
Biochemistry; 1997 Dec; 36(48):14616-26. PubMed ID: 9398180
[TBL] [Abstract][Full Text] [Related]
10. Correlation of low-barrier hydrogen bonding and oxyanion binding in transition state analogue complexes of chymotrypsin.
Neidhart D; Wei Y; Cassidy C; Lin J; Cleland WW; Frey PA
Biochemistry; 2001 Feb; 40(8):2439-47. PubMed ID: 11327865
[TBL] [Abstract][Full Text] [Related]
11. Assignment of downfield proton resonances in purine nucleoside phosphorylase immucillin-H complex by saturation-transferred NOEs.
Deng H; Lewandowicz A; Cahill SM; Furneaux RH; Tyler PC; Girvin ME; Callender RH; Schramm VL
Biochemistry; 2004 Feb; 43(7):1980-7. PubMed ID: 14967038
[TBL] [Abstract][Full Text] [Related]
12. Detection and classification of hyperfine-shifted 1H, 2H, and 15N resonances of the Rieske ferredoxin component of toluene 4-monooxygenase.
Xia B; Pikus JD; Xia W; McClay K; Steffan RJ; Chae YK; Westler WM; Markley JL; Fox BG
Biochemistry; 1999 Jan; 38(2):727-39. PubMed ID: 9888813
[TBL] [Abstract][Full Text] [Related]
13. Low-barrier hydrogen bonds and enzymatic catalysis.
Cleland WW
Arch Biochem Biophys; 2000 Oct; 382(1):1-5. PubMed ID: 11051090
[TBL] [Abstract][Full Text] [Related]
14. Fractionation factors and activation energies for exchange of the low barrier hydrogen bonding proton in peptidyl trifluoromethyl ketone complexes of chymotrypsin.
Lin J; Westler WM; Cleland WW; Markley JL; Frey PA
Proc Natl Acad Sci U S A; 1998 Dec; 95(25):14664-8. PubMed ID: 9843946
[TBL] [Abstract][Full Text] [Related]
15. The 0.78 A structure of a serine protease: Bacillus lentus subtilisin.
Kuhn P; Knapp M; Soltis SM; Ganshaw G; Thoene M; Bott R
Biochemistry; 1998 Sep; 37(39):13446-52. PubMed ID: 9753430
[TBL] [Abstract][Full Text] [Related]
16. The low barrier hydrogen bond (LBHB) proposal revisited: the case of the Asp... His pair in serine proteases.
Schutz CN; Warshel A
Proteins; 2004 May; 55(3):711-23. PubMed ID: 15103633
[TBL] [Abstract][Full Text] [Related]
17. 13C NMR study of how the oxyanion pKa values of subtilisin and chymotrypsin tetrahedral adducts are affected by different amino acid residues binding in enzyme subsites S1-S4.
O'Sullivan DB; O'Connell TP; Mahon MM; Koenig A; Milne JJ; Fitzpatrick TB; Malthouse JP
Biochemistry; 1999 May; 38(19):6187-94. PubMed ID: 10320347
[TBL] [Abstract][Full Text] [Related]
18. NMR study of the inhibition of pepsin by glyoxal inhibitors: mechanism of tetrahedral intermediate stabilization by the aspartyl proteases.
Cosgrove S; Rogers L; Hewage CM; Malthouse JP
Biochemistry; 2007 Oct; 46(39):11205-15. PubMed ID: 17824620
[TBL] [Abstract][Full Text] [Related]
19. Do enzymes change the nature of transition states? Mapping the transition state for general acid-base catalysis of a serine protease.
Bott RR; Chan G; Domingo B; Ganshaw G; Hsia CY; Knapp M; Murray CJ
Biochemistry; 2003 Sep; 42(36):10545-53. PubMed ID: 12962477
[TBL] [Abstract][Full Text] [Related]
20. Differences in binding modes of enantiomers of 1-acetamido boronic acid based protease inhibitors: crystal structures of gamma-chymotrypsin and subtilisin Carlsberg complexes.
Stoll VS; Eger BT; Hynes RC; Martichonok V; Jones JB; Pai EF
Biochemistry; 1998 Jan; 37(2):451-62. PubMed ID: 9425066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
